Q2 2014

Source filing unavailable

Q2 2014 · —

Revenue

$213.00

no prior Q2 2013 on file

Net Income

-$7.67K

no prior Q2 2013 on file

EPS Diluted

$0.00

no prior Q2 2013 on file

Operating Income-$17,102—

Margins · derived

Operating margin-8029.1%

Net margin-3599.1%

Same quarter

no prior Q2 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR